Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies

Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies

Objective To determine the harms of ezetimibe in people who need lipid-lowering treatment.Design Systematic review and meta-analysis.Data sources Randomised controlled trials and cohort studies.Eligibility criteria for selecting studies Studies comparing ezetimibe with placebo, standard care, or oth...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ling Li, Jing Li, Yang Wang, Bert Aertgeerts, Gordon Guyatt, Per Olav Vandvik, Qiukui Hao, Heyue Du, Na Su, Haoming Tian, Sheyu Li, Safi U Khan, Nicolas Delvaux, Shipeng Zhan, Geertruida Bekkering, Irbaz Riaz
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-12-01
Series:	BMJ Medicine
Online Access:	https://bmjmedicine.bmj.com/content/1/1/e000134.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Navigating Power Imbalances and Stigma in Mental Healthcare. Patient‐Reported Barriers and Facilitators to Participation in Shared Decision‐Making in Mental Health Care, a Qualitative Meta‐Summary
by: Lien Mertens, et al.
Published: (2025-04-01)

Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: systematic review and meta-analysis
by: Gordon Guyatt, et al.
Published: (2024-08-01)

Metformin for covid-19: systematic review and meta-analysis of randomised controlled trials
by: Gordon Guyatt, et al.
Published: (2025-05-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

Species Differences in Ezetimibe Glucuronidation
by: Shalom Emmanuel, et al.
Published: (2024-10-01)

Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

Simultaneous Determination of Simvastatin and Ezetimibe in Tablets by HPLC
by: D. Anantha Kumar, et al.
Published: (2009-01-01)

Values and preferences of medication use in patients for primary and secondary prevention of cardiovascular diseases: a mixed-methods exploratory study
by: Shenghan LI, et al.
Published: (2024-12-01)

Observation of ezetimibe combined with atorvastatin calcium therapy in peritoneal dialysis patients with hypercholesterolemia
by: CHEN Wen-li, et al.
Published: (2015-01-01)

Store-and-Forward Tele-Dermatology Pilot Study in Belgium: Patients and Physicians Satisfaction Study With Process Evaluation
by: Annemie Heselmans, et al.
Published: (2025-01-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia
by: Tianfu Yang, et al.
Published: (2024-01-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.
by: Tianfu Yang, et al.
Published: (2024-01-01)

Simultaneous HPTLC Estimation of Simvastatin and Ezetimibe in Tablet Dosage Form
by: Bhupendra Shrestha, et al.
Published: (2010-01-01)

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe
by: An H, et al.
Published: (2025-06-01)

Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01)

Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome
by: Mohammed Sallam, et al.
Published: (2024-11-01)

Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease
by: Yoshihiro Iwasaki, MD, PhD, et al.
Published: (2025-09-01)

Liquid Chromatographic–Mass Spectrometric Determination of Ezetimibe in Human Plasma With Validation Approach
by: Ahmed A. Alobaida
Published: (2024-12-01)

Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta‐analysis
by: Yunli Zhao, et al.
Published: (2024-09-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

Microemulsion Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe in Their Combined Dosage Forms
by: Mohammed E. A. Hammouda, et al.
Published: (2013-01-01)

Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis
by: Shujie Zhang, et al.
Published: (2025-06-01)

Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.
by: Sheyu Li, et al.
Published: (2015-01-01)

Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-Analysis.
by: Attit Baskota, et al.
Published: (2015-01-01)

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines
by: A. V. Susekov, et al.
Published: (2011-12-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)

Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry
by: I. A. Alekseeva, et al.
Published: (2025-08-01)

Monitoring Therapeutical Intervention with Ezetimibe Using Targeted Near-Infrared Fluorescence Imaging in Experimental Atherosclerosis
by: Kristof Graf, et al.
Published: (2008-03-01)

Treatment adherence, persistence, and effectiveness of fixed dose combination versus free combination therapy of rosuvastatin–ezetimibe as a lipid-lowering therapy
by: Mihail Samnaliev, et al.
Published: (2025-05-01)

NIR-Guided Coating Optimization of Omega-3 Fatty Acid Mini Soft Capsules with Pitavastatin and Ezetimibe
by: Hye-Ri Han, et al.
Published: (2024-10-01)

EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: A. Catapano, et al.
Published: (2013-08-01)

Clinicians’ experience with infographic summaries from the BMJ Rapid Recommendations: a qualitative user-testing study among residents and interns at a large teaching hospital in Switzerland
by: Thomas Agoritsas, et al.
Published: (2025-02-01)

Clinical efficacy and safety of Ezetimibe on major cardiovascular endpoints: systematic review and meta-analysis of randomized controlled trials.
by: Alessandro Battaggia, et al.
Published: (2015-01-01)

Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial
by: Xianyou Ji, et al.
Published: (2025-07-01)

Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
by: Sheyu Li, et al.
Published: (2016-01-01)

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis
by: Per Olav Vandvik, et al.
Published: (2019-10-01)

Ezetimibe Engineered L14‐8 Suppresses Advanced Prostate Cancer by Activating PLK1/TP53‐SAT1‐Induced Ferroptosis
by: Yu Zhang, et al.
Published: (2025-08-01)

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
by: Lingyan Liu, et al.
Published: (2024-01-01)